Sloan Kettering Executive Turns Over Windfall Stake in Biotech Start-Up by KATIE THOMAS and CHARLES ORNSTEIN


With the cancer center’s corporate ties under scrutiny, the hospital told employees that no one should profit personally from representing MSK on outside boards.

Published: September 29, 2018 at 02:00AM

from NYT Health https://ift.tt/2xOKzCv